Global Afoxolaner Chewable Tablets Market Growth 2025-2031

March 2025 | 81 pages | ID: G90540F04EF3EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Afoxolaner Chewable Tablets market size is predicted to grow from US$ 1415 million in 2025 to US$ 2707 million in 2031; it is expected to grow at a CAGR of 11.4% from 2025 to 2031.

Meaning Afoxolaner's chewable tablets

United States market for Afoxolaner Chewable Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Afoxolaner Chewable Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Afoxolaner Chewable Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Afoxolaner Chewable Tablets players cover Merial Toulouse, Boehringer Ingelheim, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Afoxolaner Chewable Tablets Industry Forecast” looks at past sales and reviews total world Afoxolaner Chewable Tablets sales in 2024, providing a comprehensive analysis by region and market sector of projected Afoxolaner Chewable Tablets sales for 2025 through 2031. With Afoxolaner Chewable Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Afoxolaner Chewable Tablets industry.

This Insight Report provides a comprehensive analysis of the global Afoxolaner Chewable Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Afoxolaner Chewable Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Afoxolaner Chewable Tablets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Afoxolaner Chewable Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Afoxolaner Chewable Tablets.

This report presents a comprehensive overview, market shares, and growth opportunities of Afoxolaner Chewable Tablets market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Afoxolaner Chewable Tablets
• Afoxolaner and Milbemycin Oxime Chewable Tablets

Segmentation by Application:

• Tick Infection in Dogs
• Gastrointestinal Nematode Infection in Dogs
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Merial Toulouse
• Boehringer Ingelheim

Key Questions Addressed in this Report

What is the 10-year outlook for the global Afoxolaner Chewable Tablets market?

What factors are driving Afoxolaner Chewable Tablets market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Afoxolaner Chewable Tablets market opportunities vary by end market size?

How does Afoxolaner Chewable Tablets break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Afoxolaner Chewable Tablets Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Afoxolaner Chewable Tablets by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Afoxolaner Chewable Tablets by Country/Region, 2020, 2024 & 2031
2.2 Afoxolaner Chewable Tablets Segment by Type
  2.2.1 Afoxolaner Chewable Tablets
  2.2.2 Afoxolaner and Milbemycin Oxime Chewable Tablets
2.3 Afoxolaner Chewable Tablets Sales by Type
  2.3.1 Global Afoxolaner Chewable Tablets Sales Market Share by Type (2020-2025)
  2.3.2 Global Afoxolaner Chewable Tablets Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Afoxolaner Chewable Tablets Sale Price by Type (2020-2025)
2.4 Afoxolaner Chewable Tablets Segment by Application
  2.4.1 Tick Infection in Dogs
  2.4.2 Gastrointestinal Nematode Infection in Dogs
  2.4.3 Other
2.5 Afoxolaner Chewable Tablets Sales by Application
  2.5.1 Global Afoxolaner Chewable Tablets Sale Market Share by Application (2020-2025)
  2.5.2 Global Afoxolaner Chewable Tablets Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Afoxolaner Chewable Tablets Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Afoxolaner Chewable Tablets Breakdown Data by Company
  3.1.1 Global Afoxolaner Chewable Tablets Annual Sales by Company (2020-2025)
  3.1.2 Global Afoxolaner Chewable Tablets Sales Market Share by Company (2020-2025)
3.2 Global Afoxolaner Chewable Tablets Annual Revenue by Company (2020-2025)
  3.2.1 Global Afoxolaner Chewable Tablets Revenue by Company (2020-2025)
  3.2.2 Global Afoxolaner Chewable Tablets Revenue Market Share by Company (2020-2025)
3.3 Global Afoxolaner Chewable Tablets Sale Price by Company
3.4 Key Manufacturers Afoxolaner Chewable Tablets Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Afoxolaner Chewable Tablets Product Location Distribution
  3.4.2 Players Afoxolaner Chewable Tablets Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR AFOXOLANER CHEWABLE TABLETS BY GEOGRAPHIC REGION

4.1 World Historic Afoxolaner Chewable Tablets Market Size by Geographic Region (2020-2025)
  4.1.1 Global Afoxolaner Chewable Tablets Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Afoxolaner Chewable Tablets Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Afoxolaner Chewable Tablets Market Size by Country/Region (2020-2025)
  4.2.1 Global Afoxolaner Chewable Tablets Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Afoxolaner Chewable Tablets Annual Revenue by Country/Region (2020-2025)
4.3 Americas Afoxolaner Chewable Tablets Sales Growth
4.4 APAC Afoxolaner Chewable Tablets Sales Growth
4.5 Europe Afoxolaner Chewable Tablets Sales Growth
4.6 Middle East & Africa Afoxolaner Chewable Tablets Sales Growth

5 AMERICAS

5.1 Americas Afoxolaner Chewable Tablets Sales by Country
  5.1.1 Americas Afoxolaner Chewable Tablets Sales by Country (2020-2025)
  5.1.2 Americas Afoxolaner Chewable Tablets Revenue by Country (2020-2025)
5.2 Americas Afoxolaner Chewable Tablets Sales by Type (2020-2025)
5.3 Americas Afoxolaner Chewable Tablets Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Afoxolaner Chewable Tablets Sales by Region
  6.1.1 APAC Afoxolaner Chewable Tablets Sales by Region (2020-2025)
  6.1.2 APAC Afoxolaner Chewable Tablets Revenue by Region (2020-2025)
6.2 APAC Afoxolaner Chewable Tablets Sales by Type (2020-2025)
6.3 APAC Afoxolaner Chewable Tablets Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Afoxolaner Chewable Tablets by Country
  7.1.1 Europe Afoxolaner Chewable Tablets Sales by Country (2020-2025)
  7.1.2 Europe Afoxolaner Chewable Tablets Revenue by Country (2020-2025)
7.2 Europe Afoxolaner Chewable Tablets Sales by Type (2020-2025)
7.3 Europe Afoxolaner Chewable Tablets Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Afoxolaner Chewable Tablets by Country
  8.1.1 Middle East & Africa Afoxolaner Chewable Tablets Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Afoxolaner Chewable Tablets Revenue by Country (2020-2025)
8.2 Middle East & Africa Afoxolaner Chewable Tablets Sales by Type (2020-2025)
8.3 Middle East & Africa Afoxolaner Chewable Tablets Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Afoxolaner Chewable Tablets
10.3 Manufacturing Process Analysis of Afoxolaner Chewable Tablets
10.4 Industry Chain Structure of Afoxolaner Chewable Tablets

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Afoxolaner Chewable Tablets Distributors
11.3 Afoxolaner Chewable Tablets Customer

12 WORLD FORECAST REVIEW FOR AFOXOLANER CHEWABLE TABLETS BY GEOGRAPHIC REGION

12.1 Global Afoxolaner Chewable Tablets Market Size Forecast by Region
  12.1.1 Global Afoxolaner Chewable Tablets Forecast by Region (2026-2031)
  12.1.2 Global Afoxolaner Chewable Tablets Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Afoxolaner Chewable Tablets Forecast by Type (2026-2031)
12.7 Global Afoxolaner Chewable Tablets Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Merial Toulouse
  13.1.1 Merial Toulouse Company Information
  13.1.2 Merial Toulouse Afoxolaner Chewable Tablets Product Portfolios and Specifications
  13.1.3 Merial Toulouse Afoxolaner Chewable Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Merial Toulouse Main Business Overview
  13.1.5 Merial Toulouse Latest Developments
13.2 Boehringer Ingelheim
  13.2.1 Boehringer Ingelheim Company Information
  13.2.2 Boehringer Ingelheim Afoxolaner Chewable Tablets Product Portfolios and Specifications
  13.2.3 Boehringer Ingelheim Afoxolaner Chewable Tablets Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Boehringer Ingelheim Main Business Overview
  13.2.5 Boehringer Ingelheim Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Afoxolaner ChewableTablets Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Afoxolaner ChewableTablets Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Afoxolaner ChewableTablets
Table 4. Major Players of Afoxolaner and Milbemycin Oxime ChewableTablets
Table 5. Global Afoxolaner ChewableTablets Sales byType (2020-2025) & (Box)
Table 6. Global Afoxolaner ChewableTablets Sales Market Share byType (2020-2025)
Table 7. Global Afoxolaner ChewableTablets Revenue byType (2020-2025) & ($ million)
Table 8. Global Afoxolaner ChewableTablets Revenue Market Share byType (2020-2025)
Table 9. Global Afoxolaner ChewableTablets Sale Price byType (2020-2025) & (US$/Box)
Table 10. Global Afoxolaner ChewableTablets Sale by Application (2020-2025) & (Box)
Table 11. Global Afoxolaner ChewableTablets Sale Market Share by Application (2020-2025)
Table 12. Global Afoxolaner ChewableTablets Revenue by Application (2020-2025) & ($ million)
Table 13. Global Afoxolaner ChewableTablets Revenue Market Share by Application (2020-2025)
Table 14. Global Afoxolaner ChewableTablets Sale Price by Application (2020-2025) & (US$/Box)
Table 15. Global Afoxolaner ChewableTablets Sales by Company (2020-2025) & (Box)
Table 16. Global Afoxolaner ChewableTablets Sales Market Share by Company (2020-2025)
Table 17. Global Afoxolaner ChewableTablets Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Afoxolaner ChewableTablets Revenue Market Share by Company (2020-2025)
Table 19. Global Afoxolaner ChewableTablets Sale Price by Company (2020-2025) & (US$/Box)
Table 20. Key Manufacturers Afoxolaner ChewableTablets Producing Area Distribution and Sales Area
Table 21. Players Afoxolaner ChewableTablets Products Offered
Table 22. Afoxolaner ChewableTablets Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Afoxolaner ChewableTablets Sales by Geographic Region (2020-2025) & (Box)
Table 26. Global Afoxolaner ChewableTablets Sales Market Share Geographic Region (2020-2025)
Table 27. Global Afoxolaner ChewableTablets Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Afoxolaner ChewableTablets Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Afoxolaner ChewableTablets Sales by Country/Region (2020-2025) & (Box)
Table 30. Global Afoxolaner ChewableTablets Sales Market Share by Country/Region (2020-2025)
Table 31. Global Afoxolaner ChewableTablets Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Afoxolaner ChewableTablets Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Afoxolaner ChewableTablets Sales by Country (2020-2025) & (Box)
Table 34. Americas Afoxolaner ChewableTablets Sales Market Share by Country (2020-2025)
Table 35. Americas Afoxolaner ChewableTablets Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Afoxolaner ChewableTablets Sales byType (2020-2025) & (Box)
Table 37. Americas Afoxolaner ChewableTablets Sales by Application (2020-2025) & (Box)
Table 38. APAC Afoxolaner ChewableTablets Sales by Region (2020-2025) & (Box)
Table 39. APAC Afoxolaner ChewableTablets Sales Market Share by Region (2020-2025)
Table 40. APAC Afoxolaner ChewableTablets Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Afoxolaner ChewableTablets Sales byType (2020-2025) & (Box)
Table 42. APAC Afoxolaner ChewableTablets Sales by Application (2020-2025) & (Box)
Table 43. Europe Afoxolaner ChewableTablets Sales by Country (2020-2025) & (Box)
Table 44. Europe Afoxolaner ChewableTablets Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Afoxolaner ChewableTablets Sales byType (2020-2025) & (Box)
Table 46. Europe Afoxolaner ChewableTablets Sales by Application (2020-2025) & (Box)
Table 47. Middle East & Africa Afoxolaner ChewableTablets Sales by Country (2020-2025) & (Box)
Table 48. Middle East & Africa Afoxolaner ChewableTablets Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Afoxolaner ChewableTablets Sales byType (2020-2025) & (Box)
Table 50. Middle East & Africa Afoxolaner ChewableTablets Sales by Application (2020-2025) & (Box)
Table 51. Key Market Drivers & Growth Opportunities of Afoxolaner ChewableTablets
Table 52. Key Market Challenges & Risks of Afoxolaner ChewableTablets
Table 53. Key IndustryTrends of Afoxolaner ChewableTablets
Table 54. Afoxolaner ChewableTablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Afoxolaner ChewableTablets Distributors List
Table 57. Afoxolaner ChewableTablets Customer List
Table 58. Global Afoxolaner ChewableTablets SalesForecast by Region (2026-2031) & (Box)
Table 59. Global Afoxolaner ChewableTablets RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Afoxolaner ChewableTablets SalesForecast by Country (2026-2031) & (Box)
Table 61. Americas Afoxolaner ChewableTablets Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Afoxolaner ChewableTablets SalesForecast by Region (2026-2031) & (Box)
Table 63. APAC Afoxolaner ChewableTablets Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Afoxolaner ChewableTablets SalesForecast by Country (2026-2031) & (Box)
Table 65. Europe Afoxolaner ChewableTablets RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Afoxolaner ChewableTablets SalesForecast by Country (2026-2031) & (Box)
Table 67. Middle East & Africa Afoxolaner ChewableTablets RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Afoxolaner ChewableTablets SalesForecast byType (2026-2031) & (Box)
Table 69. Global Afoxolaner ChewableTablets RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Afoxolaner ChewableTablets SalesForecast by Application (2026-2031) & (Box)
Table 71. Global Afoxolaner ChewableTablets RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. MerialToulouse Basic Information, Afoxolaner ChewableTablets Manufacturing Base, Sales Area and Its Competitors
Table 73. MerialToulouse Afoxolaner ChewableTablets Product Portfolios and Specifications
Table 74. MerialToulouse Afoxolaner ChewableTablets Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2025)
Table 75. MerialToulouse Main Business
Table 76. MerialToulouse Latest Developments
Table 77. Boehringer Ingelheim Basic Information, Afoxolaner ChewableTablets Manufacturing Base, Sales Area and Its Competitors
Table 78. Boehringer Ingelheim Afoxolaner ChewableTablets Product Portfolios and Specifications
Table 79. Boehringer Ingelheim Afoxolaner ChewableTablets Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2025)
Table 80. Boehringer Ingelheim Main Business
Table 81. Boehringer Ingelheim Latest Developments



LIST OFFIGURES

Figure 1. Picture of Afoxolaner ChewableTablets
Figure 2. Afoxolaner ChewableTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Afoxolaner ChewableTablets Sales Growth Rate 2020-2031 (Box)
Figure 7. Global Afoxolaner ChewableTablets Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Afoxolaner ChewableTablets Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Afoxolaner ChewableTablets Sales Market Share by Country/Region (2024)
Figure 10. Afoxolaner ChewableTablets Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Afoxolaner ChewableTablets
Figure 12. Product Picture of Afoxolaner and Milbemycin Oxime ChewableTablets
Figure 13. Global Afoxolaner ChewableTablets Sales Market Share byType in 2025
Figure 14. Global Afoxolaner ChewableTablets Revenue Market Share byType (2020-2025)
Figure 15. Afoxolaner ChewableTablets Consumed inTick Infection in Dogs
Figure 16. Global Afoxolaner ChewableTablets Market:Tick Infection in Dogs (2020-2025) & (Box)
Figure 17. Afoxolaner ChewableTablets Consumed in Gastrointestinal Nematode Infection in Dogs
Figure 18. Global Afoxolaner ChewableTablets Market: Gastrointestinal Nematode Infection in Dogs (2020-2025) & (Box)
Figure 19. Afoxolaner ChewableTablets Consumed in Other
Figure 20. Global Afoxolaner ChewableTablets Market: Other (2020-2025) & (Box)
Figure 21. Global Afoxolaner ChewableTablets Sale Market Share by Application (2024)
Figure 22. Global Afoxolaner ChewableTablets Revenue Market Share by Application in 2025
Figure 23. Afoxolaner ChewableTablets Sales by Company in 2025 (Box)
Figure 24. Global Afoxolaner ChewableTablets Sales Market Share by Company in 2025
Figure 25. Afoxolaner ChewableTablets Revenue by Company in 2025 ($ millions)
Figure 26. Global Afoxolaner ChewableTablets Revenue Market Share by Company in 2025
Figure 27. Global Afoxolaner ChewableTablets Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Afoxolaner ChewableTablets Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Afoxolaner ChewableTablets Sales 2020-2025 (Box)
Figure 30. Americas Afoxolaner ChewableTablets Revenue 2020-2025 ($ millions)
Figure 31. APAC Afoxolaner ChewableTablets Sales 2020-2025 (Box)
Figure 32. APAC Afoxolaner ChewableTablets Revenue 2020-2025 ($ millions)
Figure 33. Europe Afoxolaner ChewableTablets Sales 2020-2025 (Box)
Figure 34. Europe Afoxolaner ChewableTablets Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Afoxolaner ChewableTablets Sales 2020-2025 (Box)
Figure 36. Middle East & Africa Afoxolaner ChewableTablets Revenue 2020-2025 ($ millions)
Figure 37. Americas Afoxolaner ChewableTablets Sales Market Share by Country in 2025
Figure 38. Americas Afoxolaner ChewableTablets Revenue Market Share by Country (2020-2025)
Figure 39. Americas Afoxolaner ChewableTablets Sales Market Share byType (2020-2025)
Figure 40. Americas Afoxolaner ChewableTablets Sales Market Share by Application (2020-2025)
Figure 41. United States Afoxolaner ChewableTablets Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Afoxolaner ChewableTablets Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Afoxolaner ChewableTablets Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Afoxolaner ChewableTablets Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Afoxolaner ChewableTablets Sales Market Share by Region in 2025
Figure 46. APAC Afoxolaner ChewableTablets Revenue Market Share by Region (2020-2025)
Figure 47. APAC Afoxolaner ChewableTablets Sales Market Share byType (2020-2025)
Figure 48. APAC Afoxolaner ChewableTablets Sales Market Share by Application (2020-2025)
Figure 49. China Afoxolaner ChewableTablets Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Afoxolaner ChewableTablets Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Afoxolaner ChewableTablets Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Afoxolaner ChewableTablets Revenue Growth 2020-2025 ($ millions)
Figure 53. India Afoxolaner ChewableTablets Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Afoxolaner ChewableTablets Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Afoxolaner ChewableTablets Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Afoxolaner ChewableTablets Sales Market Share by Country in 2025
Figure 57. Europe Afoxolaner ChewableTablets Revenue Market Share by Country (2020-2025)
Figure 58. Europe Afoxolaner ChewableTablets Sales Market Share byType (2020-2025)
Figure 59. Europe Afoxolaner ChewableTablets Sales Market Share by Application (2020-2025)
Figure 60. Germany Afoxolaner ChewableTablets Revenue Growth 2020-2025 ($ millions)
Figure 61.France Afoxolaner ChewableTablets Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Afoxolaner ChewableTablets Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Afoxolaner ChewableTablets Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Afoxolaner ChewableTablets Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Afoxolaner ChewableTablets Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Afoxolaner ChewableTablets Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Afoxolaner ChewableTablets Sales Market Share by Application (2020-2025)
Figure 68. Egypt Afoxolaner ChewableTablets Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Afoxolaner ChewableTablets Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Afoxolaner ChewableTablets Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Afoxolaner ChewableTablets Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Afoxolaner ChewableTablets Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Afoxolaner ChewableTablets in 2025
Figure 74. Manufacturing Process Analysis of Afoxolaner ChewableTablets
Figure 75. Industry Chain Structure of Afoxolaner ChewableTablets
Figure 76. Channels of Distribution
Figure 77. Global Afoxolaner ChewableTablets Sales MarketForecast by Region (2026-2031)
Figure 78. Global Afoxolaner ChewableTablets Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Afoxolaner ChewableTablets Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Afoxolaner ChewableTablets Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Afoxolaner ChewableTablets Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Afoxolaner ChewableTablets Revenue Market ShareForecast by Application (2026-2031)